3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Completed
4
Recruiting
2
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Genitourinary
1
Conditions
Carcinoma, Renal Cell
22
Carcinoma, Hepatocellular
7
Kidney Neoplasms
6
Osteosarcoma
5
Sarcoma, Ewing
4
Neoplasm Metastasis
4
Sarcoma
3
Clear-cell metastatic renal cell carcinoma
3
Recurrence
2
Prostatic Neoplasms
2
Neuroendocrine Tumors
2
Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Adrenocortical Carcinoma
2
von Hippel-Lindau Disease
1
Wilms Tumor
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Interventions
Bevacizumab
76
Fluorouracil
56
Cetuximab
47
Leucovorin
44
Oxaliplatin
43
pembrolizumab
35
Irinotecan
34
Folfox protocol
24
Capecitabine
24
HMPL-013
22
Specimen Handling
18
trifluridine tipiracil drug combination
16
Nivolumab
15
Blood Specimen Collection
15
Panitumumab
14
regorafenib
13
Magnetic Resonance Spectroscopy
13
Trifluridine
12
Standard of Care
12
Gemcitabine
12
Biopsy
12
Cisplatin
11
sintilimab
10
Interviews as Topic
10
IFL protocol
10
Drug Therapy
10
Carboplatin
9
tislelizumab
8
Trastuzumab
8
Cyclophosphamide
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Colorectal Neoplasms
×
cabozantinib
×
Clear all
NCT06026410
2026-04-14
FIT-001
Kura Oncology, Inc.
Phase 1
Recruiting
300 enrolled
NCT03539822
2026-01-21
CAMILLA
University of Pittsburgh
Phase 1/2
Recruiting
117 enrolled